Pathstone Family Office’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pathstone Family Office’s Portfolio BIO Stock Details BIO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$298K	Buy
2023 Q2	–	Sell
2023 Q1	$275K	Sell
2022 Q4	$573K	Buy
2022 Q3	$525K	Buy
2021 Q1	–	Sell
2020 Q4	$14K	Buy